139 related articles for article (PubMed ID: 29019402)
1. A Systematic Analysis of the Binding Affinity between the Pim-1 Kinase and Its Inhibitors Based on the MM/3D-RISM/KH Method.
Hasegawa T; Sugita M; Kikuchi T; Hirata F
J Chem Inf Model; 2017 Nov; 57(11):2789-2798. PubMed ID: 29019402
[TBL] [Abstract][Full Text] [Related]
2. Understanding PIM-1 kinase inhibitor interactions with free energy simulation.
Wang X; Sun Z
Phys Chem Chem Phys; 2019 Apr; 21(14):7544-7558. PubMed ID: 30895980
[TBL] [Abstract][Full Text] [Related]
3. A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.
Schulz MN; Fanghänel J; Schäfer M; Badock V; Briem H; Boemer U; Nguyen D; Husemann M; Hillig RC
Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):156-66. PubMed ID: 21358046
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of PIM-1 kinase: a computational analysis of the binding free energies of a range of imidazo [1,2-b] pyridazines.
Doudou S; Sharma R; Henchman RH; Sheppard DW; Burton NA
J Chem Inf Model; 2010 Mar; 50(3):368-79. PubMed ID: 20175582
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets.
Shahin R; Swellmeen L; Shaheen O; Aboalhaija N; Habash M
J Comput Aided Mol Des; 2016 Jan; 30(1):39-68. PubMed ID: 26685860
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of low-nanomolar PIM kinase inhibitors.
Ishchenko A; Zhang L; Le Brazidec JY; Fan J; Chong JH; Hingway A; Raditsis A; Singh L; Elenbaas B; Hong VS; Marcotte D; Silvian L; Enyedy I; Chao J
Bioorg Med Chem Lett; 2015 Feb; 25(3):474-80. PubMed ID: 25575657
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study.
Chen Q; Wang Y; Shi S; Li K; Zhang L; Gao J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671637
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.
Akué-Gédu R; Rossignol E; Azzaro S; Knapp S; Filippakopoulos P; Bullock AN; Bain J; Cohen P; Prudhomme M; Anizon F; Moreau P
J Med Chem; 2009 Oct; 52(20):6369-81. PubMed ID: 19788246
[TBL] [Abstract][Full Text] [Related]
9. Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach.
Shao M; Yuan Y; Yu K; Lei K; Zhu G; Chen L; Xiang M
Mol Divers; 2014 May; 18(2):335-44. PubMed ID: 24519385
[TBL] [Abstract][Full Text] [Related]
10. Theoretical Analysis of Activity Cliffs among Benzofuranone-Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach.
Watanabe C; Watanabe H; Fukuzawa K; Parker LJ; Okiyama Y; Yuki H; Yokoyama S; Nakano H; Tanaka S; Honma T
J Chem Inf Model; 2017 Dec; 57(12):2996-3010. PubMed ID: 29111719
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase.
Grey R; Pierce AC; Bemis GW; Jacobs MD; Moody CS; Jajoo R; Mohal N; Green J
Bioorg Med Chem Lett; 2009 Jun; 19(11):3019-22. PubMed ID: 19414255
[TBL] [Abstract][Full Text] [Related]
12. An MM/3D-RISM approach for ligand binding affinities.
Genheden S; Luchko T; Gusarov S; Kovalenko A; Ryde U
J Phys Chem B; 2010 Jul; 114(25):8505-16. PubMed ID: 20524650
[TBL] [Abstract][Full Text] [Related]
13. Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements.
Defranchi E; Schalon C; Messa M; Onofri F; Benfenati F; Rognan D
PLoS One; 2010 Aug; 5(8):e12214. PubMed ID: 20808948
[TBL] [Abstract][Full Text] [Related]
14. Multiple time step molecular dynamics in the optimized isokinetic ensemble steered with the molecular theory of solvation: accelerating with advanced extrapolation of effective solvation forces.
Omelyan I; Kovalenko A
J Chem Phys; 2013 Dec; 139(24):244106. PubMed ID: 24387356
[TBL] [Abstract][Full Text] [Related]
15. A new method for estimating the relative binding free energy, derived from a free energy variational principle for the Pim-1-kinase-ligand and FKBP-ligand systems.
Ashida T; Kikuchi T
J Comput Aided Mol Des; 2020 Jun; 34(6):647-658. PubMed ID: 32107701
[TBL] [Abstract][Full Text] [Related]
16. Targeting Pim-1 kinase for potential drug-development.
Gadewal N; Varma A
Int J Comput Biol Drug Des; 2012; 5(2):137-51. PubMed ID: 22854122
[TBL] [Abstract][Full Text] [Related]
17. Biomolecular Simulations with the Three-Dimensional Reference Interaction Site Model with the Kovalenko-Hirata Closure Molecular Solvation Theory.
Roy D; Kovalenko A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064655
[TBL] [Abstract][Full Text] [Related]
18. Structure based drug design of Pim-1 kinase followed by pharmacophore guided synthesis of quinolone-based inhibitors.
Swellmeen L; Shahin R; Al-Hiari Y; Alamiri A; Hasan A; Shaheen O
Bioorg Med Chem; 2017 Sep; 25(17):4855-4875. PubMed ID: 28760531
[TBL] [Abstract][Full Text] [Related]
19. Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.
Casuscelli F; Ardini E; Avanzi N; Casale E; Cervi G; D'Anello M; Donati D; Faiardi D; Ferguson RD; Fogliatto G; Galvani A; Marsiglio A; Mirizzi DG; Montemartini M; Orrenius C; Papeo G; Piutti C; Salom B; Felder ER
Bioorg Med Chem; 2013 Dec; 21(23):7364-80. PubMed ID: 24139169
[TBL] [Abstract][Full Text] [Related]
20. Virtual Screening and Design with Machine Intelligence Applied to Pim-1 Kinase Inhibitors.
Schneider P; Welin M; Svensson B; Walse B; Schneider G
Mol Inform; 2020 Sep; 39(9):e2000109. PubMed ID: 33448694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
